PrognostiCheck®

Phase angle as a Prognostic Indicator

PrognostiCheck is a proprietary noninvasive measurement that depicts prognosis by illustrating the plasma cell membrane and the exchange between the intra and extracellular matrices. We use impedance plethysmography, a well-established vascular diagnostic technique to measure the values of resistance (R) and Reactance (Xc) and calculate phase angle (Pa). Phase angle is the arc tangent of Xc/R converted to degrees

Without regression analysis and across disease states and populations phase angle clearly illustrates;

• The presence and progression of disease
• Fluid Balance and Nutrition Status (without regression predictions)
• The effectiveness of a pharmacologic or non-pharmacologic treatment intervention
• Giving an opportunity to modify it to try and optimize a response
• Predicts the timing of non-acute death
• Facilitating the transition from curative-restorative to palliative-hospice care (Transitive Care TM)

Since phase angle values reflect what is happening at the cellular level they act as a “early warning system”. These vales can be used for